| #48 |
Mark Ackerman |
RTX (Raytheon) |
1 |
| #48 |
Robert Scott Evans |
Correlated Magnetics Research |
1 |
| #48 |
Clark Pan |
Genzyme |
1 |
| #48 |
Robert C. Haarde |
AT&T |
1 |
| #48 |
Gordon Cheung |
AMD |
1 |
| #48 |
Jeff Gray |
Astute Medical |
1 |
| #48 |
Jamie Lars Silva |
Finisar |
1 |
| #48 |
Anwar Kashem |
AMD |
1 |
| #48 |
Kenneth E. Sauter |
Maytag |
1 |
| #48 |
Tyler B. Cichowlas |
Saint-Gobain Abrasifs |
1 |
| #48 |
Alemseged Truneh |
Smithkline Beecham Limited |
1 |
| #48 |
Karl Lemme |
Astenjohnson |
1 |
| #48 |
Helen H. Kim |
Nanosemi |
1 |
| #48 |
Deborah C. Umbach |
Vce Ip Holding Company |
1 |
| #48 |
Shou-Ching S. Jaminet |
Beth Israel Deaconess Medical Center |
1 |
| #48 |
Jonathan Schau |
Revolabs |
1 |
| #48 |
David L. Hendry |
RTX (Raytheon) |
1 |
| #48 |
Alexander Isakov |
Brigham and Women's Hospital |
1 |
| #48 |
Mark C. Ensign |
Cristcot |
1 |
| #48 |
Robert Sackstein |
Brigham and Women's Hospital |
1 |
| #48 |
Todd A. Morneau |
Emc |
1 |
| #48 |
Daniel Abadi |
Yale University |
1 |
| #48 |
Sam Kattar |
Merck |
1 |
| #48 |
Edward R. Lee |
Genzyme |
1 |
| #48 |
Gregory Evan Fedynyshyn |
Hgst Netherlands, B.V. |
1 |
| #48 |
Todd Short |
Cisco |
1 |
| #48 |
David Bauer |
Amgen |
1 |
| #48 |
Thomas E. Hamilton, III |
Ca |
1 |
| #48 |
Glenn R. Larsen |
Genetics Institute |
1 |
| #48 |
Yaron Dar |
Emc |
1 |
| #48 |
Joseph Mooney |
Harvard University |
1 |
| #48 |
Jianguo Yang |
Genzyme |
1 |
| #48 |
David A. Griffith |
Pfizer |
1 |
| #48 |
Gregory Gazda |
Merck |
1 |
| #48 |
Thomas Chittenden |
Immunogen |
1 |
| #48 |
George Avgerinos |
AbbVie |
1 |
| #48 |
Anne Celia Petrofsky |
The General Hospital |
1 |
| #48 |
Donald Paul Orofino, II |
The Mathworks |
1 |
| #48 |
Xiaowen Peng |
Enanta Pharmaceuticals |
1 |
| #48 |
Danny Macari |
Hologic |
1 |
| #48 |
Doreen Rao |
Boston Scientific Scimed |
1 |
| #48 |
Fidelma Russo |
Emc Ip Holding Company |
1 |
| #48 |
Mark Dinsmore |
Photoelectron |
1 |
| #48 |
Qi Jin |
IBM |
1 |
| #48 |
Thomas E. Kazior |
RTX (Raytheon) |
1 |
| #48 |
Binbin Lin |
Emc Ip Holding Company |
1 |
| #48 |
Francis L. Leard |
Seurat Technologies |
1 |
| #48 |
Nunzio Sciammetta |
Merck |
1 |
| #48 |
Carl Offner |
Ab Initio Technology |
1 |
| #48 |
Marija Ilic |
MIT |
1 |